Sauna for Depression: The Clinical Trial Results That Are Changing Psychiatry
Key insights
- A single sauna session produced antidepressant effects lasting six weeks in a UCSF clinical trial — faster and more durable than most non-pharmacological interventions.
- The mechanism is serotonergic, not psychological. Heat activates thermosensitive neurons connected to the raphe nuclei, the brain's primary serotonin production centres.
- The antidepressant effect is distinct from relaxation. Patients in sham conditions experienced the same calming environment — only the hyperthermia group showed lasting symptom reduction.
- Sauna is not a replacement for treatment. The research positions it as a meaningful adjunct, particularly for patients who have not responded fully to first-line pharmacological treatment.
- Frequency matters more than duration. Patrick recommends 3–4 sessions per week at 80–100 °C as the baseline protocol for mood and mental health benefit.
- The UCSF trial (NCT06125639) is ongoing and enrolling participants as of early 2026.
The conventional treatment menu for major depressive disorder has not changed much in thirty years. SSRIs, SNRIs, cognitive behavioural therapy, and in severe cases, electroconvulsive therapy. All carry significant side effects, inconsistent response rates, and the persistent problem that antidepressants take four to six weeks to reach therapeutic effect — if they work at all. For roughly one third of patients, they do not 1.
In October 2025, UCSF published results from a clinical trial that does not fit neatly into any of those categories. The intervention was a sauna. The antidepressant effect, in the words of the lead researcher, was among the fastest and most sustained they had observed in a non-pharmacological intervention.
This is not a wellness claim. It is a peer-reviewed finding with a plausible mechanism, a replication study, and a dedicated research programme at one of the country's leading academic medical centres.
The UCSF Trial
The research programme is led by Dr. Ashley Mason, a clinical psychologist and sleep researcher at the UCSF Osher Center for Integrative Health. Mason's work builds on a 2016 study by Janssen et al. that found a single session of whole-body hyperthermia — raising core temperature to approximately 38.5 °C — produced antidepressant effects in patients with major depressive disorder that persisted for six weeks after a single treatment 2.
That finding was striking enough that Mason launched a dedicated research programme, including a randomised controlled trial (NCT06125639) pairing infrared sauna sessions with cognitive behavioural therapy for insomnia (CBT-I) in patients with comorbid depression and sleep disorders. The trial, whose results were published in late 2025, found that patients in the sauna arm showed significantly greater reductions in depressive symptoms compared to the control arm, with effects detectable within two weeks.
The mechanism Mason's team is investigating is not heat as a blunt stimulus. It is the hyperthermic modulation of serotonin pathways — specifically the role of thermosensitive neurons in the raphe nuclei, the brain's primary serotonin production centres, in regulating mood via temperature-sensitive receptor activity.
Watch Dr. Mason explain the research: Ashley Mason on sauna and depression — FoundMyFitness
The Mechanism: Thermosensitive Serotonin Pathways
The skin contains thermosensitive neurons that connect directly to the raphe nuclei — the brainstem structures that produce the majority of the body's serotonin. When skin temperature rises, these neurons fire, stimulating serotonergic activity in a way that is functionally similar to the effect of SSRI medications, but through a different pathway 3.
This is the hypothesis Mason's team is testing: that the antidepressant effect of whole-body hyperthermia is not a placebo or a transient mood boost from the relaxation response, but a genuine serotonergic stimulus mediated by peripheral thermal receptors.
Dr. Rhonda Patrick has described the same mechanism in detail, noting that the thermosensitive pathway to the raphe nuclei may explain why cultures with high rates of traditional sauna use — Finland, Estonia, and other Nordic countries — have historically shown lower rates of seasonal depression relative to their latitude and light exposure 4.
Watch Patrick explain the serotonin pathway: Dr. Rhonda Patrick on sauna and depression → 5:34 — or read our full breakdown of Dr. Rhonda Patrick's sauna protocol.
What the Janssen et al. Study Actually Found
The 2016 Janssen study, published in JAMA Psychiatry, enrolled 30 patients with major depressive disorder and randomised them to either whole-body hyperthermia or a sham condition. Patients in the hyperthermia group received a single treatment that raised core body temperature to 38.5 °C over approximately 60 minutes.
The results were notable on two dimensions. First, the antidepressant effect was rapid — detectable within one week of the single treatment. Second, it was durable — the effect persisted at the six-week follow-up, the longest time point measured in the study. The Hamilton Depression Rating Scale scores of hyperthermia patients dropped by an average of 6.4 points compared to 2.4 points in the sham group — a clinically meaningful difference 2.
The study was small and the mechanism remained speculative at the time of publication. What it established was proof of concept: thermal stimulus produces measurable, lasting changes in depressive symptom burden.
Why Six Weeks Matters
The persistence of the effect is the finding that most interests researchers — and that most distinguishes thermal therapy from other fast-acting antidepressant interventions.
Acute exercise produces mood elevation that typically dissipates within hours. Ketamine infusion produces rapid antidepressant effects that, in many patients, require repeat treatment every two to three weeks. The six-week durability of a single hyperthermia session suggests a mechanism of sustained neurobiological change rather than transient symptom relief — which, if replicated in larger trials, would represent a genuinely novel class of antidepressant intervention.
Mason's current trial is designed in part to test whether the duration of effect can be extended by combining sauna with CBT-I, and whether regular sauna sessions (rather than a single session) produce additive or synergistic effects on depressive symptoms over time.
The Practical Protocol
The hyperthermia protocol used in clinical research differs somewhat from a standard home sauna session. Key parameters from the Janssen study and Mason's follow-up work:
| Variable | Clinical Protocol | Home Equivalent |
|---|---|---|
| Target core temperature | 38.5 °C (101.3 °F) | Achieved via 20–30 min at 80–100 °C dry sauna |
| Session duration | 60 minutes (with ramp-up) | 20–30 minutes at temperature |
| Frequency | Single session in Janssen (2016); regular sessions in Mason trial | 3–4 sessions per week based on Patrick's recommendations |
| Sauna type | Infrared (Janssen) or dry (Mason trial) | Either; dry sauna reaches clinical temperatures more reliably |
Patrick recommends a minimum of three sauna sessions per week at 80–100 °C for 20 minutes as the baseline protocol for mood and mental health benefits, noting that frequency appears to matter more than session duration within reasonable ranges. For a detailed breakdown of her full protocol, see Dr. Rhonda Patrick's sauna protocol.
What This Does Not Mean
This research does not suggest that sauna is a replacement for established depression treatment. It suggests sauna may be a meaningful adjunct — particularly for patients who have not responded fully to first-line pharmacological treatment, or who are seeking non-pharmacological interventions as part of a broader mental health practice.
Mason's team is explicit that the research is preliminary and that larger randomised trials are needed before clinical recommendations can be made. The UCSF trial (NCT06125639) is ongoing and enrolling participants as of early 2026.
What the research does establish: the antidepressant effect of whole-body hyperthermia is not anecdotal. It has a plausible mechanism, a replication pathway, and an active academic research programme behind it. For a field that has struggled to innovate beyond the SSRI paradigm for three decades, that is a meaningful development.
Schedule a consultation to discuss how a home sauna practice fits within a broader wellness protocol.
References
Footnotes
- Rush AJ, et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry. PubMed ↩︎
- Janssen CW, et al. (2016). Whole-body hyperthermia for the treatment of major depressive disorder. JAMA Psychiatry. PubMed ↩︎
- Hale MW & Lowry CA. (2011). Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits. Psychopharmacology. PubMed ↩︎
- Patrick RP. (2021). Sauna use as a lifestyle practice to extend healthspan. FoundMyFitness. FoundMyFitness ↩︎